col0,col1,col2,col3,col4,col5,col6,col7
Belimumab,Benlysta,immunosuppressive drug,Belimumab,25,lupus nephritis,US pregnancy category C,biopharmaceutical
Siltuximab,Sylvant,antineoplastic,Siltuximab,37,Castleman's disease,US pregnancy category C,monoclonal antibody
Belimumab,Benlysta,immunosuppressive drug,Belimumab,25,lupus nephritis,US pregnancy category C,monoclonal antibody
Siltuximab,Sylvant,antineoplastic,Siltuximab,37,Castleman's disease,US pregnancy category C,medication
